# Ketryx Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ketryx

- Industry: Software
- Headquarters: Cambridge, US
- Website: www.ketryx.com
- Total disclosed funding: $50M
- Latest round: Series B (Jul 18, 2025)
- Investors on record: 5

## About

Based in Massachusetts, US, and founded in 2021 by CEO Erez Kaminski, Ketryx Corporation, a.k.a. Ketryx operates as a software company that focuses on developing medical software for regulation and quality assurance. In July 2025, Ketryx Corporation raised USD 39 million in series B funding led by new investor Transformation Capital, with participation from returning investors Lightspeed Venture Partners, E14 Fund, Ubiquity Ventures, and 53 Stations. 

The company provides a connected lifecycle management platform for regulated medical applications that enables the healthcare sector to reduce complexity and costs across their IT systems, control risks with medical-grade cybersecurity, empower their developers and engineers with their necessary tools, and more. The platform offers a wide range of features, including requirements management, development management, configuration management, post-market surveillance, change control management, and more.

The company plans to utilize the July 2025 funding to expand its Vienna site and hire additional members of its AI, software engineering, and life sciences compliance teams.

## Funding rounds

- Series B, Jul 18, 2025, $36M — Lightspeed Venture Partners, E14 Fund, Transformation Capital, Ubiquity Ventures, 53 Stations
- Series A, Nov 6, 2023, $14M — Lightspeed Venture Partners, E14 Fund, Ubiquity Ventures

## Investors

- Lightspeed Venture Partners (https://capitalatlas.ai/funds/lightspeed-venture-partners) — Series A, Series B
- E14 Fund (https://capitalatlas.ai/funds/e14-fund) — Series A, Series B
- Ubiquity Ventures (https://capitalatlas.ai/funds/ubiquity-ventures) — Series A, Series B
- Transformation Capital (https://capitalatlas.ai/funds/transformation-capital) — Series B
- 53 Stations (https://capitalatlas.ai/funds/53-stations) — Series B